Cancer Outcomes and Risks after Immunotherapy-Associated Diabetes Diagnosis
18 May, 2025
A retrospective cohort of 43 CPI-DM patients treated at UCSF was examined. Patients were divided into groups based on CPI therapy continuation: those who resumed within 90 days, those who delayed resumption, and those who permanently discontinued treatment. Researchers analysed irAE occurrences, cancer progression, and overall survival, using statistical models, including Fisher’s exact tests, Kaplan-Meier methods, and Cox regression. Read More…
